We cover the entire life cycle of biomedical device development, from design to preclinical validation in both large and small animals. We offer comprehensive solutions to research challenges through our “Cutting-Edge Biomedical Solutions” (CEBS).
The Spanish Strategy for Science, Technology and Innovation includes the “National Scientific and Technological Infrastructure Map (ICTS)”. These ICTS are large installations, resources, facilities and services, unique in its kind, that are dedicated to cutting edge and high quality research and technological development, as well as to promote exchange, transmission and preservation of knowledge, technology transfer and innovation. These are facilities of different scientific areas distributed throughout the Spanish territory and are OPEN to competitive access to users of the whole research community in the public and private sector. NANBIOSIS inclusion in the Map of ICTS was recognized by the Spanish Government in 2014 and periodically renewed till now.
NANBIOSIS is managed under the ISO9001 certification for standard quality control system
Redes sociales
Áreas de actividad
Ámbitos de aplicación
Biotecnología SanitariaServicios profesionales y de I+D
Biotecnología Sanitaria: Áreas de actividad
Biofármacos/BiomarcadoresCélulas madre/Cultivos celulares/Mantenimiento de cultivos celularesTerapia tisular y biomaterialesDiagnóstico in vitro/por imagen/Dispositivos medicosDrug delivery/Drug development/Drug Discovery/ScreeningOtros
Servicios de I+D
BioinformáticaDesarrollo de kits biotecnológicosEmpresas CRO / CMO / SMOGenómicaNanotecnologías y biología in silicoProteómicaOtros
Biotecnología Agroalimentaria: Alimentación
Detección de sustanciasSeguridad alimentariaOtros
Biotecnología Sanitaria: Áreas terapéuticas
Enfermedades cardiovasculares y sistema circulatorioEnfermedades infecciosas/genéticas y rarasEnfermedades InflamatoriasInmunologíaOncologíaOftalmología y optometríaSistema respiratorio y pulmonarOtros
Revolutionizing healthcare with recombinant proteins — unleashing safe, targeted drug delivery and tissue regeneration for groundbreaking therapeutic treatments.
Accelerate your nanomedicine’s journey to market with NANBIOSIS: tailored in vitro characterization services ensuring preclinical validation success, saving crucial time in the development process.
Fast-track your nanomedicine’s path to market with NANBIOSIS: tailored preclinical studies, cutting-edge imaging, and comprehensive analytics, all while ensuring ethical compliance and regulatory adherence.
Oncología
Inmunología
Enfermedades infecciosas
Sistema digestivo y hepatología
Enfermedades cardiovasculares y sistema circulatorio
Revolutionize disease treatment with our new Cutting-Edge Solution — precise enzyme-loaded nanovesicles, offering targeted therapies for various disorders with optimal efficacy and safety.
Enhance the safety and efficacy of your biomedical device by evaluating its antimicrobial properties and behavior in realistic physiological environments.
Develop and validate customized 3D-bioprinted scaffolds with in vivo models, bridging advanced biomaterials research and real-world regenerative medicine applications.